IBRANCE Trademark

Trademark Overview

On Thursday, June 19, 2014, a trademark application was filed for IBRANCE with the United States Patent and Trademark Office. The USPTO has given the IBRANCE trademark a serial number of 86314613. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, August 21, 2025. This trademark is owned by Pfizer Inc.. The IBRANCE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical information services, namely, providing information related to oncological diseases and disorders; on-line information services, namely, providing information related to oncological diseases and disorders
ibrance

General Information

Serial Number86314613
Word MarkIBRANCE
Filing DateThursday, June 19, 2014
Status800 - REGISTERED AND RENEWED
Status DateThursday, August 21, 2025
Registration Number4928206
Registration DateTuesday, March 29, 2016
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 28, 2014

Trademark Statements

Description of MarkThe mark consists of the word "IBRANCE" with a half circle design.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical information services, namely, providing information related to oncological diseases and disorders; on-line information services, namely, providing information related to oncological diseases and disorders

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 27, 2014
Primary Code044
First Use Anywhere DateTuesday, June 30, 2015
First Use In Commerce DateTuesday, June 30, 2015

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, June 23, 2014NEW APPLICATION ENTERED
Thursday, September 18, 2014EXAMINERS AMENDMENT -WRITTEN
Friday, September 19, 2014EXAMINER'S AMENDMENT ENTERED
Friday, June 27, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 28, 2014NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, September 17, 2014ASSIGNED TO EXAMINER
Thursday, September 18, 2014ASSIGNED TO LIE
Thursday, September 18, 2014EXAMINER'S AMENDMENT MAILED
Tuesday, September 23, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 8, 2014NOTICE OF PUBLICATION
Thursday, June 18, 2015SOU TEAS EXTENSION RECEIVED
Thursday, June 18, 2015SOU EXTENSION 1 FILED
Thursday, June 18, 2015SOU EXTENSION 1 GRANTED
Tuesday, December 8, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, December 8, 2015USE AMENDMENT FILED
Friday, January 22, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 19, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 28, 2014PUBLISHED FOR OPPOSITION
Tuesday, December 23, 2014NOA MAILED - SOU REQUIRED FROM APPLICANT
Saturday, June 20, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Saturday, January 30, 2016STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 12, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 12, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 12, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 12, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, March 12, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 12, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 14, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 22, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 23, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Tuesday, March 29, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, August 23, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 15, 2020REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
Monday, March 29, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, March 2, 2022TEAS SECTION 8 & 15 RECEIVED
Tuesday, August 23, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 23, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 10, 2025TEAS SECTION 8 & 9 RECEIVED
Thursday, August 21, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 21, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, August 21, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, August 21, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, March 29, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

ibrance information oncological diseases disorders related providing services namely line medical